---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-080683"
form_type: "8-K"
ticker: "ORIC"
cik: "0001796280"
company_name: "Oric Pharmaceuticals, Inc."
filed_at: "2022-03-21T23:59:59+00:00"
generated_at: "2026-06-26T21:28:00.586849+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "low"
source: SEC EDGAR
---

# ORIC Pharmaceuticals hosts Q4/FY2021 call; corporate presentation furnished as Exhibit 99.1

## Summary
- Company held conference call on March 21, 2022 to discuss Q4 and full year 2021 financial results and operational update.
- Corporate presentation attached as Exhibit 99.1 but specific financial figures are not included in the filing text.
- Filing under Item 7.01 Regulation FD; presentation is furnished, not filed.

## SEC filing metadata
- accession: 0001193125-22-080683
- form_type: 8-K
- ticker: ORIC
- cik: 0001796280
- company_name: Oric Pharmaceuticals, Inc.
- filed_at: 2022-03-21T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1796280/000119312522080683/0001193125-22-080683-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1796280/000119312522080683/d337066d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-080683
- JSON: https://secwatch.observer/filing/0001193125-22-080683.json
- Plain text: https://secwatch.observer/filing/0001193125-22-080683.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.